# EXAGEN INC.

EXAGEN INC. is a public company listed on Nasdaq as XGN, headquartered in Vista, CA, United States.

## Company overview

- **Legal name:** EXAGEN INC.
- **Former names in filing history:** EXAGEN DIAGNOSTICS INC (2003-12-29 to 2017-05-18)
- **Classification:** Public company
- **Industry (SIC):** 8071 — Services-Medical Laboratories
- **Headquarters:** Vista, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **Ticker:** Nasdaq: XGN
- **SEC CIK:** 0001274737

## About

EXAGEN INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001274737, and its reported industry is Services-Medical Laboratories. In 10-K filed on 2026-03-10, it reported annual revenue of USD 66,575,000; net income of USD -19,951,000; total assets of USD 58,022,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2025 (period ended 2025-12-31)

- **Revenue:** $66.6M (USD 66,575,000)
- **Net income:** -$20.0M (USD -19,951,000)
- **Total assets:** $58.0M (USD 58,022,000)
- **Cash and equivalents:** $32.2M (USD 32,220,000)
- **Operating cash flow:** -$13.6M (USD -13,625,000)

### FY2024 (period ended 2024-12-31)

- **Revenue:** $55.6M (USD 55,641,000)
- **Net income:** -$15.1M (USD -15,115,000)
- **Total assets:** $44.7M (USD 44,689,000)
- **Cash and equivalents:** $22.0M (USD 22,036,000)
- **Operating cash flow:** -$13.3M (USD -13,279,000)

### FY2023 (period ended 2023-12-31)

- **Revenue:** $52.5M (USD 52,548,000)
- **Net income:** -$23.7M (USD -23,689,000)
- **Total assets:** $56.9M (USD 56,944,000)
- **Cash and equivalents:** $36.5M (USD 36,493,000)
- **Operating cash flow:** -$14.5M (USD -14,462,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $45.6M (USD 45,563,000)
- **Net income:** -$47.4M (USD -47,387,000)
- **Total assets:** $86.2M (USD 86,221,000)
- **Cash and equivalents:** $62.4M (USD 62,391,000)
- **Operating cash flow:** -$32.1M (USD -32,144,000)

## Recent SEC filings

- Form 10-Q — filed 2026-08-04 — period 2026-06-30 — 10-Q
- Form 8-K — filed 2026-08-04 — period 2026-08-04 — 10-Q
- Form 8-K — filed 2026-06-09 — period 2026-06-09 — 8-K
- Form 10-Q — filed 2026-05-11 — period 2026-03-31 — 10-Q
- Form 8-K — filed 2026-05-11 — period 2026-05-11 — 8-K
- Form DEF 14A — filed 2026-04-27 — period 2026-06-09 — DEF 14A
- Form 8-K — filed 2026-04-23 — period 2026-04-17 — 8-K
- Form 10-K — filed 2026-03-10 — period 2025-12-31 — 10-K
- Form 8-K — filed 2026-03-10 — period 2026-03-10 — 8-K
- Form 8-K — filed 2026-01-12 — period 2026-01-11 — 8-K
- Form 10-Q — filed 2025-11-04 — period 2025-09-30 — 10-Q
- Form 8-K — filed 2025-11-04 — period 2025-11-04 — 8-K

---

Updated: 2026-10-23T05:02:54.863002+00:00

Canonical page: https://altss.com/profile/exagen-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology